chr16-1209319-C-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The NM_021098.3(CACNA1H):c.3651C>T(p.Arg1217Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000213 in 1,597,716 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R1217R) has been classified as Likely benign.
Frequency
Consequence
NM_021098.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -10 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1H | ENST00000348261.11  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
| CACNA1H | ENST00000569107.6  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454990.2 | |||
| CACNA1H | ENST00000711493.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 34 | ENSP00000518778.1 | ||||
| CACNA1H | ENST00000565831.7  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000455840.1 | |||
| CACNA1H | ENST00000711450.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 35 | ENSP00000518762.1 | ||||
| CACNA1H | ENST00000564231.6  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 35 | 1 | ENSP00000457555.2 | |||
| CACNA1H | ENST00000638323.1  | c.3612C>T | p.Arg1204Arg | synonymous_variant | Exon 17 of 35 | 5 | ENSP00000492267.1 | |||
| CACNA1H | ENST00000562079.6  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 34 | 1 | ENSP00000454581.2 | |||
| CACNA1H | ENST00000711438.1  | c.3612C>T | p.Arg1204Arg | synonymous_variant | Exon 17 of 34 | ENSP00000518754.1 | ||||
| CACNA1H | ENST00000711482.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 36 | ENSP00000518771.1 | ||||
| CACNA1H | ENST00000711485.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 35 | ENSP00000518774.1 | ||||
| CACNA1H | ENST00000711455.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 36 | ENSP00000518768.1 | ||||
| CACNA1H | ENST00000711483.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 35 | ENSP00000518772.1 | ||||
| CACNA1H | ENST00000711456.1  | c.3651C>T | p.Arg1217Arg | synonymous_variant | Exon 17 of 34 | ENSP00000518769.1 | ||||
| CACNA1H | ENST00000621827.2  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | 6 | ENSP00000518766.1 | ||||
| CACNA1H | ENST00000637236.3  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 34 | 5 | ENSP00000492650.2 | ||||
| CACNA1H | ENST00000639478.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491945.1 | ||||
| CACNA1H | ENST00000640028.1  | n.*1564C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1  | n.*3098C>T | non_coding_transcript_exon_variant | Exon 16 of 34 | ENSP00000518758.1 | |||||
| CACNA1H | ENST00000711448.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518760.1 | |||||
| CACNA1H | ENST00000711449.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518761.1 | |||||
| CACNA1H | ENST00000711451.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518763.1 | |||||
| CACNA1H | ENST00000711452.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518764.1 | |||||
| CACNA1H | ENST00000711453.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518765.1 | |||||
| CACNA1H | ENST00000711484.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518773.1 | |||||
| CACNA1H | ENST00000711486.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 37 | ENSP00000518775.1 | |||||
| CACNA1H | ENST00000711487.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 36 | ENSP00000518776.1 | |||||
| CACNA1H | ENST00000711488.1  | n.3651C>T | non_coding_transcript_exon_variant | Exon 17 of 35 | ENSP00000518777.1 | |||||
| CACNA1H | ENST00000640028.1  | n.*1564C>T | 3_prime_UTR_variant | Exon 17 of 35 | 5 | ENSP00000491488.1 | ||||
| CACNA1H | ENST00000711442.1  | n.*3098C>T | 3_prime_UTR_variant | Exon 16 of 34 | ENSP00000518758.1 | 
Frequencies
GnomAD3 genomes   AF:  0.0000131  AC: 2AN: 152220Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.00000440  AC: 1AN: 227460 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.0000221  AC: 32AN: 1445496Hom.:  0  Cov.: 31 AF XY:  0.0000208  AC XY: 15AN XY: 719546 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000131  AC: 2AN: 152220Hom.:  0  Cov.: 33 AF XY:  0.0000269  AC XY: 2AN XY: 74366 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV    Uncertain:1 
- -
Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at